Insights

Crypto VC focus Variant is an early-stage crypto venture capital firm investing in an internet where users become owners, presenting opportunities to discuss blockchain infrastructure, wallet integration, and crypto startup collaborations.

Tech stack fit Utilizes AWS, WordPress, Google Workspace, Sentry, Vercel, and analytics like Piwik PRO Core, indicating potential interest in cloud services, monitoring, hosting, CMS, collaboration tools, and performance analytics partnerships.

Growth potential Reported revenue range of several tens of millions suggests a growing fund with appetite for strategic tech investments and platform partnerships to support portfolio companies.

Hiring scope Team size 11-50 implies a lean organization with close-knit decision making, presenting SDR-led outreach opportunities around fundraising, LP relations, and co-investment programs.

Industry alignment Similar company peers operate in biotechnology and data-driven sectors, highlighting cross-vertical collaboration opportunities for portfolio synergies, technical tooling, and market intelligence sharing.

Variant Tech Stack

Variant uses 8 technology products and services including iCIMS, Amazon Web Services, WordPress, and more. Explore Variant's tech stack below.

iCIMS

Applicant Tracking Systems

Amazon Web Services

Cloud Hosting

WordPress

Content Management System

Google Workspace

Sentry

Issue Trackers

Vercel

Platform As A Service

WP Engine

Platform As A Service

Piwik PRO Core

Web Analytics

Variant Email Formats	Example	Percentage
First@variant.fund	John@variant.fund	100%

Variant Email Formats

Example

Percentage

First@variant.fund

John@variant.fund

100%

Frequently Asked Questions

What is Variant's stock symbol?

Variant is a publicly traded company; the company's stock symbol is IMPCX.

What is Variant's official website and social media links?

Variant's official website is variant.fund and has social profiles on LinkedIn.

How much revenue does Variant generate?

As of August 2026, Variant's annual revenue is estimated to be $25M - $50M.

What is Variant's NAICS code?

Variant's NAICS code is 52391 - Miscellaneous Intermediation.

How many employees does Variant have currently?

As of August 2026, Variant has approximately 22 employees across 3 continents, including North America, Asia and Europe. Key team members include Advisor: S. G. Explore Variant's employee directory with LeadIQ.

What industry does Variant belong to?

Variant operates in the Venture Capital and Private Equity Principals industry.

What technology does Variant use?

Variant's tech stack includes iCIMS, Amazon Web Services, WordPress, Google Workspace, Sentry, Vercel, WP Engine and Piwik PRO Core.

What is Variant's email format?

Variant's email format typically follows the pattern of First@variant.fund. Find more Variant email formats with LeadIQ.

When was Variant founded?

Variant was founded in 2020.

Variant

Q: What is Variant's official website and social media links?

Variant's official website is variant.fund. Variant has social profiles on LinkedIn.

Q: How many employees does Variant have currently?

Variant has approximately 22 employees.

Q: What technology does Variant use?

Variant's tech stack includes ZURB Foundation, Google Fonts API, Swiper, Twitter Ads, Headless UI.

Q: What is Variant's NAICS code?

Variant's NAICS code is 52391 (Miscellaneous Intermediation).

Venture Capital and Private Equity PrincipalsNew York, United States11-50 Employees

Variant is an early-stage venture capital firm focused on crypto startups. It aims to fund ventures that envision an internet where users become owners. Operating within the venture capital and private equity space, the firm concentrates on opportunities at the intersection of crypto and ownership-enabled networks.

Variant is based in New York City and maintains a small to mid-sized team. The organization provides online resources, including a writing and ideas section and a disclosures page, hosted on its website.

Insights

Similar companies to Variant

Namocell

BenchSci

ProteinQure

CytoReason

Envisagenics

OneThree Biotech

Phase Genomics